Dutagen Soft Capsule 0.5 mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 capsule (0.5mg) once daily. As exposure to the capsule contents may cause irritation of the oropharyngeal mucosa, swallow this medicine whole without chewing or breaking it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or elderly patients. As there are no data on administration of this medicine to patients with hepatic impairment, the recommended dose in patients with hepatic impairment has not been established.

This medication can be absorbed through the skin, so women who are pregnant or may become pregnant should not directly handle or touch this medication. If the contents of the medication come into contact with skin, wash it immediately with soap and water. Children should also be kept away from contact with the contents, and if contact occurs, they should be washed immediately. Women, children under 18, and individuals with a known allergy to this medication or similar ingredients should not take this medication. Adult men planning to conceive should carefully consider the use of this medication based on a doctor's judgment, as it may affect reproductive capacity. Patients with urinary problems or compromised liver function should exercise caution when taking this medication, especially those with severely compromised liver function. Caution is advised if taken with strong CYP3A4 inhibitors, as it may increase the blood concentration of this medication. Side effects related to the reproductive system, such as erectile dysfunction, decreased libido, and ejaculation disorders, may occur during this medication period, and these symptoms may persist after discontinuation of the medication. Rare cases of breast-related adverse reactions such as gynecomastia or breast tenderness have also been reported. This medication is used for benign prostatic hyperplasia or male pattern baldness treatment, and regular PSA tests and digital rectal exams are necessary for assessing the risk of prostate cancer. Since the PSA levels may decrease after taking this medication, they should be re-evaluated based on new standards 3-6 months later. PSA levels will return to baseline within 6 months after stopping this medication. Rare cases of worsening heart failure have been reported in patients with heart failure, but causality is unclear. Blood donation is prohibited while taking this medication, and at least 6 months must pass after the last dose before blood donation is allowed. There are no specific antidotes for overdose, so proper supportive treatment must be received if symptoms are suspected. This medication should be kept out of reach of children and stored in its original container to prevent degradation or misuse. Driving or operating machinery is not known to be affected during the use of this medication.

• Erectile dysfunction
• decreased libido
• ejaculation disorders
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication should be stored in a sealed container to prevent exposure to air and moisture, preferably in a cool place below 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.

Appearance

An opaque, cloudy yellow oblong soft capsule filled with colorless transparent content.

Package unit

30 capsules (10 capsules/PTPX3)